Skip to main content

Table 1 Patient serum analysis on molecular sensitization patterns

From: Honey bee venom re-challenge during specific immunotherapy: prolonged cardio-pulmonary resuscitation allowed survival in a case of near fatal anaphylaxis

 

rApi m1

rApi m2

rApi m3

rApi m4

rApi m10

Patient serum analysis (time of sting provocation)

IgE kU/l

89.2

 > 100

1.85

9.94

10.5

IgG4 ug/l

 > 50,000

7285

272

 > 50,000

241

 

rApi m1

rApi m2

rApi m3

rApi m4

rApi m10

Comparison data: serum of a protected patient

IgE kU/l

1.6

15.9

0.22

2.3

2.42

IgG4 ug/l

 > 50,000

15,190

19,320

 > 50,000

1800

 

rApi m1

rApi m2

rApi m3

rApi m4

rApi m5

rApi m10

Date**

Patient serum analysis (time of sting provocation; 1 month later; after 6 months of VIT)

IgE kU/l

89.2

 > 100

1.85

9.94

9.9

10.5

T + 3 days

IgG4 ug/l

 > 50,000

7285

272

 > 50,000

1890

241

T + 3 days

IgG4 ug/l

 > 50,000

7692

339

 > 50,000

2470

533

T + 28 days

IgG4 ug/l

 > 50,000

10,640

1716

 > 50,000

3834

 < 200

T + 7 months *

IgG4 ug/l

     

 < 200

T + 4 years°

  1. *6 months after reaching triple VIP maintenance dose (100000 SQE plus 300 μg HBV concomitant with Omalizumab)
  2. **T stands for day of sting challenge
  3. °in between well tolerated 3 years after sting challenge, under VIT mot Omalizumab and 200 ug HBV